Chia-Chi Wang

12PUBLICATIONS
14CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Medical biotechnology diagnostics (incl. biosensors)Language documentation and descriptionCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 16, 2024
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease.

Shao-Wen Wang, Tsung-Han Hsieh, Yu-Ming Cheng

|Aug 03, 2023
Letter to the Editor: Statement of steatotic liver disease-A great leap toward the global standardization.

Chia-Chi Wang, Yu-Ming Cheng, Jia-Horng Kao

|Jun 02, 2023
Predictors of Liver Dysfunction After Transhepatic Arterial Chemo-embolization in Hepatocellular Carcinoma Patients.

Kun-Lin Cheng, Yu-Ming Cheng, Cheng-Yi Chan

|Dec 05, 2022
Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications.

Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao

|May 08, 2021
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).

Wei-Fan Hsu, Pei-Chein Tsai, Chi-Yi Chen

Pageof 2